-
1 Comment
Memphasys Limited is currently in a long term downtrend where the price is trading 26.0% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Its net income has increased by 3.7% to $-719K since the same quarter in the previous year.
Finally, its free cash flow grew by 124.3% to $363K since the same quarter in the previous year.
Based on the above factors, Memphasys Limited gets an overall score of 3/5.
| ISIN | AU000000MEM5 |
|---|---|
| Industry | Biotechnology |
| Sector | Healthcare |
| CurrencyCode | AUD |
| Exchange | AU |
| Dividend Yield | 0.0% |
|---|---|
| Target Price | None |
| Market Cap | 17M |
| Beta | -0.02 |
| PE Ratio | 0.0 |
Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix, a novel automated device for quickly and gently separating high quality sperm from a raw semen sample for use in human IVF procedures. In addition, the company's product pipeline include ROSA, a rapid oxidative stress assay; Samson Device, rapid equine pregnancy prediction assay; SemPort, a central lab human semen analysis from distantly located donors; and AI-Port. An ambient temperature semen transport device used for animal artificial insemination. Memphasys Limited was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. The company was incorporated in 2006 and is based in Homebush, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MEM.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
